Preview

Astrakhan medical journal

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Nasal microbiota in multiple sclerosis

https://doi.org/10.17021/1992-6499-2025-4-67-74

Abstract

The study of the role of microbiota in various neurodegenerative diseases is expanding, In this case, the microflora of the nose can be involved in the pathological process through the “nose – brain” pathway. Analysis of the nasal microbiota in patients with multiple sclerosis may provide insight into the progression of the disease and develop new approaches to improving the effectiveness of treatment and preventive measures. The purpose of the study. To analyze the microbiota of the nasal cavity depending on the duration of the course of multiple sclerosis and its clinical manifestations. Materials and methods. 96 рatients with multiple sсlerosis and 40 рraсtically healthy individuals in the сomрarison grouр were examined using clinical and bacteriological methods. A comparative study of the nature of the nasal microflora was carried out depending on the duration of the disease, the age of the patients and the level of disability. Statistical processing of the obtained results was carried out by calculating the Pearson agreement criterion χ2 using the “Statistica 12.0” program. The results of the study. In patients with multiple sclerosis, a significant change in the qualitative characteristics of the nasal microbiota was found, manifested by a significant increase in the colonization properties of opportunistic microorganisms of the species Staphylococcus aureus, Staphylococcus epidermidis and Escherichia coli. Increased representation of more pathogenic microorganisms (coagulase-positive staphylococcus, hemolytic escherichiae) in patients with significant neurological lesions. The conducted studies demonstrate significant changes in the nasal microbiota in patients with a clinically pronounced disease, characterizing the “nose – brain” relationship. Conclusion. The nasal mucosal microbiome in multiple sclerosis has unique characteristics, and the prevalence of opportunistic bacteria correlates with the duration of the disease and the severity of symptoms. The potential benefits of correcting these abnormalities require further study. 

About the Authors

I. V. Dukhanina
Yaroslavl State Medical University
Russian Federation

Inna V. Dukhanina, Cand. Sci. (Pharm.), Associate Professor of the Department,

Yaroslavl.



M. Yu. Gulneva
Yaroslavl State Medical University
Russian Federation

Marina Yu. Gulneva, Dr. Sci. (Med.), Associate Professor, Associate Professor of the Department,

Yaroslavl.



E. V. Malafeeva
Yaroslavl State Medical University
Russian Federation

Elvira V. Malafeeva, Dr. Sci. (Med.), Professor, Professor of the Department,

Yaroslavl.



D. V. Lendoeva
Medical and Genetic Research Center named after Academician N. P. Bochkov
Russian Federation

Darina V. Lendoeva, Resident,

Moscow.



References

1. Thangaleela S., Sivamaruthi B. S., Kesika P., Bharathi M., Chaiyasut C. Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging-A Review. Microorganisms. 2022; 10 (7): 1405. doi: 10.3390/microorganisms10071405.

2. Castillo-Álvarez F., Marzo-Sola M. E. Role of the gut microbiota in the development of various neurological diseases. Neurologia (Engl Ed). 2022; 37 (6): 492–498. doi: 10.1016/j.nrleng.2019.03.026.

3. Nakhal M. M., Yassin L. K., Alyaqoubi R., Saeed S., Alderei A., Alhammadi A., Alshehhi M., Almehairbi A., Houqani S., BaniYas S., Qanadilo H., Ali B. R., Shehab S., Statsenko Y., Meribout S., Sadek B., Akour A., Hamad M. I. K. The Microbiota-Gut-Brain Axis and Neurological Disorders: A Comprehensive Review. Life (Basel). 2024; 6; 14 (10): 1234. doi: 10.3390/life14101234.

4. Ullah H., Arbab S., Tian Y., Liu C. Q., Chen Y., Qijie L, Khan M. I. U., Hassan I. U., Li K. The gut microbiota-brain axis in neurological disorder. Neurosci. 2023; 4; 17: 1225875. doi: 10.3389/fnins.2023.1225875.

5. Xie J., Tian S., Liu J., Cao R., Yue P., Cai X., Shang Q., Yang M., Han L., Zhang D. K. Dual role of the nasal microbiota in neurological diseases-An unignorable risk factor or a potential therapy carrier. Pharmacol Res. 2022; 179: 106189. doi: 10.1016/j.phrs.2022.106189.

6. Kristensson K. Microbes’ roadmap to neurons. Nat. Rev. Neurosci. 2011; 12: 345–357. doi: 10.1038/nrn3029.

7. Branton W. G., Lu J. Q., Surette M. G., Holt R. A., Lind J., Laman J. D., Power C. Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis. Sci Rep. 2016; 28 (6): 37344.

8. Back U., Moller B. B., Bog-Hansen T. C. Host resistance to lipopolysaccharides in the pathogenesis of multiple sclerosis and membranoproliferative glomerulonephritis. Lancet. 1976; 24, 2 (7978): 188–192.

9. Esaulov A. S., Mitrofanova N. N., Melnikov V. L. Bakteriologicheskiy metod laboratornoy diagnostiki = Bacteriological method of laboratory diagnostics. Penza: Penza State University; 2015: 71 p.

10. Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983; 33 (11): 1444–1452. doi: 10.1212/wnl.33.11.1444.

11. Titus H. E., Chen Y., Podojil J. R., Robinson A. P., Balabanov R., Popko B., Miller S. D. Pre-clinical and Clinical Implications of “Inside-Out” vs. “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis. Front Cell Neurosci. 2020; 27 (14): 599717.

12. Thompson A. J., Banwell B. L., Barkhof F., Carroll W. M., Coetzee T., Comi G., Correale J., Fazekas F., Filippi M., Freedman M. S., Fujihara K., Galetta S. L., Hartung H. P., Kappos L., Lublin F .D., Marrie R. A., Miller A. E., Miller D. H., Montalban X., Mowry E. M., Sorensen P. S., Tintoré M., Traboulsee A. L., Trojano M., Uitdehaag B. M. J., Vukusic S., Waubant E., Weinshenker B. G, Reingold S. C, Cohen J.A. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet. Neurology. 2018 Feb; 17(2): 162–173.

13. Maheshwari K., Gupta R., Sharma R., Kaur A., Vashist A., Aggarwa G. Nasal microbiome dynamics: decoding the intricate nexus in the progression of respiratory and neurological diseases. Microbiol. 2024; 19: 1–16.


Review

For citations:


Dukhanina I.V., Gulneva M.Yu., Malafeeva E.V., Lendoeva D.V. Nasal microbiota in multiple sclerosis. Astrakhan medical journal. 2025;20(4):67-74. (In Russ.) https://doi.org/10.17021/1992-6499-2025-4-67-74

Views: 22


ISSN 1992-6499 (Print)